비교리스트

 카트 문의
시장보고서
상품코드
1571847

세계의 혈당 모니터링 시스템 시장

Blood Glucose Monitoring Systems
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 92 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈당 모니터링 시스템 세계 시장은 2030년까지 400억 달러에 달할 전망

2023년에 208억 달러로 추정되는 혈당 모니터링 시스템 세계 시장은 2023-2030년간 CAGR 9.8%로 성장하여 2030년에는 400억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 셀프 모니터링은 CAGR 9.3%로 성장을 지속하고, 분석 기간이 끝날 때 214억 달러에 달할 것으로 예측됩니다. 지속적인 부문의 성장률은 분석 기간 동안 CAGR 10.5%로 추정됩니다.

미국 시장은 54억 달러로 추정, 중국은 CAGR 13.0%로 성장 예측

미국의 혈당 모니터링 시스템 시장은 2023년 54억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 91억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 13.0%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.7%와 7.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 7.5%로 성장할 것으로 예측됩니다.

세계 혈당 모니터링 시스템 시장 - 주요 동향과 촉진요인 요약

기술의 진보로 혈당 모니터링 시스템은 어떻게 진화하고 있는가?

혈당 모니터링(BGM) 시스템 시장은 당뇨병 환자에게 보다 정확하고 편리하며 사용자 친화적인 혈당 모니터링을 실현하는 기술의 발전으로 큰 진화를 이루고 있습니다. 손가락을 찌르는 테스트와 같은 기존의 혈당치 모니터링 방법은 최소한의 침습성으로 포도당 수준의 실시간 추적을 제공하는 지속적인 포도당 모니터링(CGM) 시스템을 대체하고 있습니다. CGM 시스템은 피하에 삽입된 센서로 포도당 수준을 지속적으로 측정하므로 환자와 건강 관리 제공업체는 동향과 변동을 보다 정확하게 모니터링할 수 있습니다. 간헐적 모니터링에서 지속적인 모니터링으로의 이동은 적시 개입과 보다 맞춤 치료 계획을 가능하게 함으로써 당뇨병 관리를 개선합니다.

CGM 기술과 통합된 웨어러블 디바이스도 인기를 끌고 있으며 환자에게 하루 종일 혈당치를 추적하는 편리하고 비침습적인 방법을 제공합니다. 이러한 기기는 종종 모바일 앱에 연결되어 사용자가 실시간으로 포도당 데이터를 표시하고 위험한 변동에 대한 알림을 받거나 의료 서비스 제공업체와 정보를 공유할 수 있습니다. 또한 인공지능(AI)과 데이터 분석의 진보는 포도당 변동을 예측하고 환자가 예방 조치를 취하는 데 도움이 되는 예측 모델링을 가능하게 하여 혈당 모니터링 시스템의 정확도를 향상시킵니다.

CGM 시스템은 당뇨병 관리에 어떤 영향을 미치는가?

지속 포도당 모니터링(CGM) 시스템은 포도당 수준에 대한 보다 상세하고 실시간 데이터를 제공함으로써 당뇨병 관리에 큰 영향을 미치고 있습니다. 하루 종일 여러 번 손가락을 찔러서 검사해야 하는 기존의 혈당 측정기와 달리 CGM 시스템은 지속적인 데이터 스트림을 제공하므로 사용자는 포도당 동향과 패턴을 모니터링할 수 있습니다. 이 실시간 모니터링을 통해 환자는 다양한 활동, 다이어트 및 약물이 포도당 수치에 어떤 영향을 미치는지 파악할 수 있으며, 다이어트, 운동 및 인슐린 사용에 대한 충분한 정보를 바탕으로 결정 내릴 수 있습니다.

CGM 시스템은 또한 포도당 수준이 너무 높거나 너무 낮을 때 경고를 보내 환자의 안전성을 높이고 고혈당이나 저혈당의 위험한 에피소드를 예방하는 데 도움이 됩니다. 이 기능은 급격한 포도당 변동의 위험이 높은 1형 당뇨병 환자에게 특히 유용합니다. CGM 시스템은 또한 건강 관리 제공업체가 장기간에 걸쳐 상세한 포도당 데이터에 액세스할 수 있게 하여 보다 정확한 평가 및 치료 계획을 조정할 수 있도록 합니다. 포도당 데이터의 질과 빈도를 향상시킴으로써 CGM 시스템은 당뇨병 관리를 변화시키고 세계 수백만 명의 환자 결과를 개선하고 있습니다.

모바일 앱과 AI와의 데이터 통합은 어떻게 혈당 모니터링을 개선하는가?

모바일 앱과 AI와의 데이터 통합은 혈당 모니터링 시스템의 기능을 크게 개선하여 당뇨병 관리를 더욱 편리하고 개인화합니다. 최근 포도당 모니터와 CGM 장치의 대부분은 블루투스 기술을 탑재하여 사용자가 포도당 수준을 추적하고 관리할 수 있는 스마트폰 앱과 동기화할 수 있습니다. 이러한 앱은 종종 시각적 차트, 기록 데이터 및 추세 분석을 제공하며 사용자가 장기간 포도당 패턴을 이해하는 데 도움이 됩니다. 일부 앱은 식사, 신체 활동 및 투약 기록을 기록하고 당뇨병 관리의 전반적인 모습을 파악할 수 있습니다.

AI를 탑재한 알고리즘은 과거의 데이터를 분석하고 과거의 동향을 바탕으로 미래의 포도당 값을 예측함으로써 혈당 모니터링 시스템의 예측 기능을 강화하고 있습니다. 이를 통해 환자는 포도당의 급상승과 급강하를 예측하고 그에 따라 행동과 인슐린 투여를 조정할 수 있습니다. AI는 또한 실시간 포도당 측정치에 따라 인슐린 수준을 자동으로 조정하는 인공 췌장 시스템으로도 알려진 폐 루프 인슐린 전달 시스템의 개발에도 사용됩니다. 이러한 데이터 통합과 인공지능의 진보는 혈당 모니터링을 보다 사전활성화하고 환자 부담을 줄이고, 당뇨병 관리 전체를 개선하고 있습니다.

혈당 모니터링 시스템 시장의 성장을 가속하는 요인은?

혈당 모니터링 시스템 시장의 성장은 세계의 당뇨병 유병률 증가, 포도당 모니터링 기술의 발전, 웨어러블 디바이스 채택 확대 등 여러 요인에 의해 야기됩니다. 당뇨병 세계의 이환율이 특히 개발도상국에서 상승을 계속하고 있는 가운데, 환자의 병리 관리를 지원하는 효과적인 포도당 모니터링 솔루션에 대한 수요가 높아지고 있습니다. 이러한 장치는 보다 정확하고 실시간 데이터를 제공하고 침습적인 검사의 필요성을 줄이기 때문에 기존의 손가락 스틱 검사에서 지속적인 포도당 모니터링(CGM) 시스템으로의 이동은 주요 촉진요인입니다.

CGM 시스템과 모바일 앱의 통합, AI, 데이터 분석 등의 기술적 진보도 포도당 모니터링을 보다 편리하고 정확하게 개별화함으로써 시장 성장을 가속하고 있습니다. 소비자가 건강 관리를 위해 비침습적이고 연결된 솔루션을 선호하기 때문에 웨어러블 디바이스의 인기가 높아지고 있는 것도 시장 확대에 기여하고 있습니다. 게다가 고령화, 앉기 쉬운 라이프스타일과 건강에 해로운 식생활 증가가 2형 당뇨병의 유병률 증가로 이어져 혈당 모니터링 시스템 수요를 더욱 촉진하고 있습니다.

CGM 시스템에 대한 규제 지원과 상환 정책도 특히 북미와 유럽 등 신흥국 시장에서의 채용을 촉진하고 있습니다. 의료 제공업체와 보험 회사는 당뇨병 관리를 개선하고 당뇨병 합병증과 관련된 장기적인 비용을 줄이는 CGM 시스템의 가치를 인식하고 있습니다. 마지막으로 당뇨병과 포도당 모니터링의 중요성에 대한 의식이 높아짐에 따라 환자가 보다 적극적으로 병리학을 관리하고 합병증을 예방할 수 있게 되면서 이러한 시스템의 채용 확대로 이어지고 있습니다.

조사 대상 기업 예(전 36건)

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.10.24

Global Blood Glucose Monitoring Systems Market to Reach US$40.0 Billion by 2030

The global market for Blood Glucose Monitoring Systems estimated at US$20.8 Billion in the year 2023, is expected to reach US$40.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$21.4 Billion by the end of the analysis period. Growth in the Continuous segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 13.0% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$5.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Blood Glucose Monitoring Systems Market – Key Trends & Drivers Summarized

How Are Blood Glucose Monitoring Systems Evolving with Technological Advancements?

The blood glucose monitoring (BGM) systems market is undergoing significant evolution due to advancements in technology, which are making glucose monitoring more accurate, convenient, and user-friendly for patients with diabetes. Traditional methods of monitoring blood glucose levels, such as finger-prick tests, are being replaced by continuous glucose monitoring (CGM) systems that offer real-time tracking of glucose levels with minimal invasiveness. CGM systems use sensors inserted under the skin to measure glucose levels continuously, allowing patients and healthcare providers to monitor trends and fluctuations more accurately. This shift from intermittent to continuous monitoring is improving diabetes management by enabling timely interventions and more personalized treatment plans.

Wearable devices integrated with CGM technology are also gaining popularity, providing patients with a convenient, non-invasive way to track their blood glucose levels throughout the day. These devices are often connected to mobile apps, allowing users to view their glucose data in real-time, receive alerts about dangerous fluctuations, and share information with their healthcare providers. Additionally, advancements in artificial intelligence (AI) and data analytics are enhancing the accuracy of blood glucose monitoring systems by enabling predictive modeling, which can anticipate glucose fluctuations and help patients take preventive measures.

What Impact Do CGM Systems Have on Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are having a profound impact on diabetes management by offering more detailed and real-time data on glucose levels, allowing patients to take proactive steps in managing their condition. Unlike traditional blood glucose meters, which require multiple finger-stick tests throughout the day, CGM systems provide a continuous stream of data, enabling users to monitor glucose trends and patterns. This real-time monitoring allows patients to identify how different activities, meals, and medications affect their glucose levels, helping them make informed decisions about their diet, exercise, and insulin use.

CGM systems also enhance safety for patients by sending alerts when glucose levels are too high or too low, helping to prevent dangerous episodes of hyperglycemia or hypoglycemia. This feature is particularly beneficial for patients with type 1 diabetes, who are at greater risk of sudden glucose fluctuations. CGM systems also enable healthcare providers to access detailed glucose data over time, allowing for more accurate assessments and adjustments to treatment plans. By improving the quality and frequency of glucose data, CGM systems are transforming diabetes care and improving outcomes for millions of patients worldwide.

How Is Data Integration with Mobile Apps and AI Improving Blood Glucose Monitoring?

Data integration with mobile apps and AI is significantly improving the functionality of blood glucose monitoring systems, making diabetes management more convenient and personalized. Many modern glucose monitors and CGM devices are now equipped with Bluetooth technology, allowing them to sync with smartphone apps where users can track and manage their glucose levels. These apps often provide visual charts, historical data, and trend analysis, helping users understand their glucose patterns over time. Some apps also allow users to log meals, physical activity, and medications, providing a holistic view of their diabetes management.

AI-powered algorithms are enhancing the predictive capabilities of blood glucose monitoring systems by analyzing historical data and predicting future glucose levels based on past trends. This can help patients anticipate glucose spikes or drops and adjust their behavior or insulin dosing accordingly. AI is also being used to develop closed-loop insulin delivery systems, also known as artificial pancreas systems, which automatically adjust insulin levels in response to real-time glucose readings. These advancements in data integration and AI are making blood glucose monitoring more proactive, reducing the burden on patients and improving overall diabetes management.

What Factors Are Driving the Growth of the Blood Glucose Monitoring Systems Market?

The growth in the blood glucose monitoring systems market is driven by several factors, including the increasing prevalence of diabetes worldwide, advancements in glucose monitoring technology, and the growing adoption of wearable devices. As the global incidence of diabetes continues to rise, particularly in developing countries, there is a growing demand for effective glucose monitoring solutions that help patients manage their condition. The shift from traditional finger-stick testing to continuous glucose monitoring (CGM) systems is a key growth driver, as these devices offer more accurate, real-time data and reduce the need for invasive testing.

Technological advancements, such as the integration of CGM systems with mobile apps, AI, and data analytics, are also driving market growth by making glucose monitoring more convenient, accurate, and personalized. The growing popularity of wearable devices is another factor contributing to the expansion of the market, as consumers increasingly prefer non-invasive, connected solutions for managing their health. In addition, the aging population and the rise in sedentary lifestyles and unhealthy diets are leading to an increased prevalence of type 2 diabetes, further fueling the demand for blood glucose monitoring systems.

Regulatory support and reimbursement policies for CGM systems are also driving adoption, particularly in developed markets such as North America and Europe. Healthcare providers and insurance companies are recognizing the value of CGM systems in improving diabetes management and reducing the long-term costs associated with diabetes complications. Finally, increasing awareness about diabetes and the importance of glucose monitoring is leading to greater adoption of these systems, as patients become more proactive in managing their condition and preventing complications.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Blood Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Drives Demand for Blood Glucose Monitoring Systems
    • Increasing Focus on Personalized Healthcare Expands the Addressable Market for Continuous Glucose Monitoring (CGM) Systems
    • Technological Advancements in Blood Glucose Monitoring Devices Propel Growth in Accuracy and Usability
    • Growing Demand for Wearable and Non-Invasive Blood Glucose Monitoring Devices Fuels Innovation
    • Rising Awareness of Diabetes Management and Preventive Care Strengthens Market Growth for Blood Glucose Monitors
    • Integration of AI and Data Analytics in Glucose Monitoring Systems Expands Opportunities for Personalized Treatment
    • Increasing Focus on Remote Patient Monitoring and Telehealth Solutions Expands Market Adoption of Blood Glucose Monitoring Systems
    • Growing Use of Continuous Glucose Monitoring Systems in Pediatric and Geriatric Diabetes Management Drives Demand
    • Rising Adoption of Smart Insulin Pens and Automated Insulin Delivery Systems Propels Demand for Integrated Monitoring Solutions
    • Increasing Use of Blood Glucose Monitoring Systems in Hospital and Clinical Settings Expands Market Applications
    • Technological Advancements in Sensor Accuracy and Battery Life Strengthen the Business Case for Wearable Glucose Monitors
    • Rising Demand for Glucose Monitoring Apps and Digital Health Platforms Drives Adoption of Connected Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Fingertip Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Alternate Site Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Self / Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Type 1 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Type 2 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Blood Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: India 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: India 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: India 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: India 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 322: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 325: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 328: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 334: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 337: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 340: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 346: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 349: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 352: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 358: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 361: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 364: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 370: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 373: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 376: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 379: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 382: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 385: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 388: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 391: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제